---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-006093"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2022-04-25T23:59:59+00:00"
generated_at: "2026-06-26T05:04:14.608289+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Medpace Q1 revenue up 27.3% to $330.9M; EPS $1.69 vs $1.14 YoY

## Summary
- Revenue $330.9M, +27.3% YoY; constant-currency organic growth +28.1%.
- GAAP EPS $1.69 diluted vs $1.14 prior year; net income margin 18.5% (prev 16.7%).
- Net new business awards $423.0M (+18.8% YoY); book-to-bill ratio 1.28x.
- Backlog grew 28.0% to $2.1B from $1.6B as of Mar 31, 2021.
- EBITDA $70.4M (+31.3%); margin 21.3% vs 20.6% prior year.

## SEC filing metadata
- accession: 0000950170-22-006093
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2022-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000095017022006093/0000950170-22-006093-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000095017022006093/medp-20220425.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-006093
- JSON: https://secwatch.observer/filing/0000950170-22-006093.json
- Plain text: https://secwatch.observer/filing/0000950170-22-006093.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.